AllQuantitative Report
logoArgusNovember 24, 2020

ANIP: Rating increased to a HOLD

Symbols
ANIP
Sector(s)
Healthcare
Rating
Premium
Current Price
$32.13
Price Target
$NaN
Earnings Estimate
Premium
Summary

ANI Pharmaceuticals Inc develops, manufactures and markets generic prescription pharmaceuticals, made in the U.S.A.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE